Literature DB >> 7778888

Evolution of a grounded theory: conflict resolution through culture brokering.

M A Jezewski1.   

Abstract

This article describes the evolution of the middle-range substantive theory of culture brokering. The theory was generated by first conducting a concept analysis that yielded 12 attributes of the concept of culture brokering. The concept analysis was accomplished using the anthropology, health-related, and business literature. In addition, data from an interpretive ethnographic study were used to further develop the concept of culture brokering. The theory was then generated from four grounded theory studies. Each study was used to frame the grounded theory model and to strengthen and refine the categories and links between categories within the basic social process of culture brokering. The culture brokering theory can guide the practice of nurses in situations where conflict is present in the health care interaction. The theory is grounded in the experiences of nurses attempting conflict resolution in the context of health care interactions.

Mesh:

Year:  1995        PMID: 7778888     DOI: 10.1097/00012272-199503000-00004

Source DB:  PubMed          Journal:  ANS Adv Nurs Sci        ISSN: 0161-9268            Impact factor:   1.824


  3 in total

1.  Improving health equity: the promising role of community health workers in Canada.

Authors:  Sara Torres; Ronald Labonté; Denise L Spitzer; Caroline Andrew; Carol Amaratunga
Journal:  Healthc Policy       Date:  2014

Review 2.  Recruiting underserved populations to dermatologic research: a systematic review.

Authors:  Chaya R Spears; Bridgit V Nolan; Jenna L O'Neill; Thomas A Arcury; Joseph G Grzywacz; Steven R Feldman
Journal:  Int J Dermatol       Date:  2011-04       Impact factor: 2.736

Review 3.  Survivorship navigation outcome measures: a report from the ACS patient navigation working group on survivorship navigation.

Authors:  Mandi Pratt-Chapman; Melissa A Simon; Angela K Patterson; Betsy C Risendal; Steven Patierno
Journal:  Cancer       Date:  2011-08       Impact factor: 6.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.